Disease progress in patients with Morbus Fabry after switching from agalsidase beta to agalsidase alpha

Autor:	S, Reidt, M, Namdar, A, Serra, P A, Krayenbühl, C, Gruner, D I, Keller, T F, Lüscher, C, Schmied
Rok vydání:	2013
Předmět:	Isoenzymes Male Treatment Outcome Drug Substitution Echocardiography alpha-Galactosidase Disease Progression Fabry Disease Humans Enzyme Replacement Therapy Drug Monitoring Glomerular Filtration Rate
Zdroj:	Internal medicine journal. 44(2)
ISSN:	1445-5994
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::ae64c52cdfa8f88025479af4667a1909 https://pubmed.ncbi.nlm.nih.gov/24528819 Zobrazit plný text záznamu Plný text